For the first time in history, a patient awaiting a lung transplantation will be able to benefit from therapeutic virtual reality sessions for preventive purposes of postoperative psychological trauma, thanks to the partnership between C2Care and AP-HM (Public Assistance – Marseille Hospitals)
“Hyper Immersion” – To prevent psychological trauma
The reawakening process after transplantation surgery can be very violent for the patient, creating a risk for psychological trauma such as anxieties and depressive disorders. These consequences can lead to post-operative complications that now may be reduced. C2Care has together with AP-HM developed a method called “Habitation Therapy” that implements Virtual Reality solutions prior to surgery to prepare the patient with the purpose to overcome these medical-psychological risks.
How it’s done – with the C2Care 3D Scanner
The Virtual Reality solutions by C2Care scans the hospital room in 360 degrees, which recreates in every detail the environment the patient will wake up in. Even the medical equipment in the room and that the patients wakes up with after the surgery is reconstructed in 3D, and shown inside the VR-headset.
Pre surgery, the patient does 3 training sessions of 45 minutes each together with a therapist. This simulation of the post-surgery wake-up process, mentally prepares the patient for the real situation. By doing this, post-surgery complications may be reduced:
“We hope to achieve a 30% decrease in post operation anxieties” Doctor COIFFARD
The product will be available on the market in the beginning of 2020
This innovative VR-method is passing the end phase in testing. C2Care hopes that it will be put into practice in Q1 2020. Ap-HM carries out about 50 lung transplantations per year, and this preventive therapy method will be proposed to 25 randomly selected patients. In a longer perspective, C2Care could provide this solution to 400 lung transplant patients in France, and 8000 worldwide. This type of preventive therapy could also be adapted to other types of medical and surgical interventions.
This scientific project is financially supported by the research department of the AP-HM and by the association Maryse Pour la Vie, with the support of the Department of Intensive and Resuscitation Medicine. Pr. L. PAPAZIAN, Department of Rare Respiratory Diseases, Cystic Fibrosis, Pr. M. REYNAUD-GAUBERT, and Department of Thoracic Surgery and Esophageal Diseases of Pr. P. THOMAS